GlassScriptPhysician profile
Annie J Kim
NPI 1023853488
$1,291.41
in general payments reported to CMS, 2019-2025
13 companies · $708 in 2025
The $708 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $584 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $248.90 | 2024 | Qbrexza |
| Boston Scientific Corporation | $233.12 | 2025 | Infinion 16, General - Pain Management, Wavewriter Alpha Prime 16 |
| E.R. Squibb & Sons, L.L.C. | $167.76 | 2024 | Sotyktu |
| Collegium Pharmaceutical, INC. | $154.70 | 2024-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $96.02 | 2025 | Inceptiv |
| Globus Medical, INC. | $78.51 | 2025 | Senza |
| Biotronik Nro, INC. | $75.39 | 2025 | Prospera |
| Vertex Pharmaceuticals Incorporated | $63.56 | 2024-2025 | |
| Abbvie INC. | $53.63 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $50.04 | 2024-2025 | Exparel, Iovera, Zilretta |
| Tersera Therapeutics LLC | $30.21 | 2025 | Prialt |
| Nevro Corp. | $23.88 | 2024 | Senza |
| Tonix Medicines, INC. | $15.69 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.